Pfizer, Valneva To Launch Clinical Trial Of Experimental Lyme Disease Vaccine

USA Today (8/8, Weintraub) reports Pfizer and French partner Valneva “are launching a large clinical trial of an experimental vaccine that would be the first to prevent Lyme disease, the companies announced Monday.” VLA15, “if proven safe and effective......